Xylem price target raised to $146 from $125 at Argus

Argus analyst John Eade raised the firm’s price target on Xylem to $146 from $125 and keeps a Buy rating on the shares. The company stands to benefit from trends in water conservation, drinking water sanitation, the acquisition of water technology company Evoqua, and government regulation, the analyst tells investors in a research note. Argus further sees margin expansion for Xylem from new growth opportunities, noting that the company is using partnerships and other acquisitions to expand its offerings, especially in the utility and industrial end markets.